Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors

Margot P. Cleary, Frederick C. Phillips, Susan C. Getzin, Tina L. Jacobson, Michelle K. Jacobson, Trace A. Christensen, Subhash C. Juneja, Joseph P. Grande, Nita J. Maihle

Research output: Contribution to journalArticle

130 Scopus citations

Abstract

Elevated body weight is a risk factor for postmenopausal breast cancer and is associated with increased incidence of spontaneous and chemically induced mammary tumors (MTs) in rodents. In this study, genetically obese Lepob Lepob female mice that overexpress human TGF-α (transforming growth factor-alpha) were used to assess the role of body weight on oncogene-induced MT development in comparison to lean counterparts. MMTV (mouse mammary tumor virus)-TGF-α and Lep strain mice were crossed to produce TGF-α/Lep+ Lep+ (homozygous lean), TGF-α/Lep+ Lepob (heterozygous lean) and TGF-α/Lepob Lepob (homozygous obese) genotypes. Body weights were determined weekly and mice palpated for the presence of MTs until 104 weeks of age. Despite their significantly higher body weight, obese TGF-α/Lepob Lepob mice failed to develop MTs. MTs were detected between 48 and 104 weeks of age for 26/39 TGF-α/Lep+ Lepob mice and for 19/38 TGF-α/Lep+ Lep+ mice between 67 and 104 weeks of age. Although MT incidence was not statistically different between the lean groups, age of MT detection tended to be younger for TGF-α/Lep+ Lepob mice (p < 0.09). There were significant effects of both genotype and MTs on final body weight, that is, TGF-α/Lep+ Lepob mice weighed more than homozygous lean mice, and mice with MTs weighed more than those without MTs. TGF-α/Lepob Lepob mice are not a good model to evaluate the effect of body weight on MT development possibly due to leptin deficiency. However, the finding that increased body weight is associated with increased oncogene-induced MT development within the normal weight range provides experimental support for the role of body weight in breast cancer.

Original languageEnglish (US)
Pages (from-to)205-215
Number of pages11
JournalBreast Cancer Research and Treatment
Volume77
Issue number3
DOIs
StatePublished - Feb 1 2003

Keywords

  • Body weight
  • Heterozygous
  • Leptin
  • Mammary tumors
  • Obesity
  • Ovarian tumors
  • Postmenopausal breast cancer
  • Transgenic mice

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Genetically obese MMTV-TGF-α/Lep<sup>ob</sup> Lep<sup>ob</sup> female mice do not develop mammary tumors'. Together they form a unique fingerprint.

  • Cite this

    Cleary, M. P., Phillips, F. C., Getzin, S. C., Jacobson, T. L., Jacobson, M. K., Christensen, T. A., Juneja, S. C., Grande, J. P., & Maihle, N. J. (2003). Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. Breast Cancer Research and Treatment, 77(3), 205-215. https://doi.org/10.1023/A:1021891825399